# The Effect of Bezafibrate on Cholestatic Itch

> **NCT02701166** · PHASE3 · UNKNOWN · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 84 (estimated)

## Conditions studied

- Primary Biliary Cholangitis
- Primary Sclerosing Cholangitis
- Secondary Sclerosing Cholangitis

## Interventions

- **DRUG:** Bezafibrate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02701166
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2018-02
- **Final completion:** 2018-04
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2016-03-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701166, "The Effect of Bezafibrate on Cholestatic Itch". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02701166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*